Report of Foreign Issuer (6-k)
March 06 2019 - 6:16AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of: March 2019
Commission file number: 001-36578
BIOBLAST PHARMA LTD.
(Translation of registrant’s name
into English)
PO Box 318, Tel-Aviv, Israel 6100201
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F
x
Form
40-F
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____
CONTENTS
This Report of Foreign Private Issuer
on Form 6-K of the Registrant consists of the press release, which is attached hereto as Exhibit 99.1, issued by the
Registrant on March 6, 2019, announcing the effectiveness of an eight to one reverse split of the Registrant’s share
capital and a related amendment to the Company’s articles of association.
Exhibit 99.1 is incorporated by reference
into the registration statements on Form S-8 (File No. 333-203114 and File No. 333-210459) of the Registrant, filed with the Securities
and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by
documents or reports subsequently filed or furnished.
Exhibit No.
99.1
|
Press Release issued by Bioblast Pharma Ltd. on March 6, 2019.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Bioblast Pharma Ltd.
|
|
(Registrant)
|
|
|
|
|
|
|
|
By:
|
/s/ Dr. Dalia Megiddo
|
|
Name:
|
Dr. Dalia Megiddo
|
|
|
Interim Chief Executive Officer
|
Date: March 6, 2019
Bioblast Pharma Ltd. (NASDAQ:ORPN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bioblast Pharma Ltd. (NASDAQ:ORPN)
Historical Stock Chart
From Apr 2023 to Apr 2024